{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T21:25:07Z","timestamp":1746653107265,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T00:00:00Z","timestamp":1536192000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13256-018-1787-8","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T10:21:11Z","timestamp":1535019671000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of intravitreal dexamethasone on macular edema in von Hippel-Lindau disease assessed using swept-source optical coherence tomography: a case report"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5896-5313","authenticated-orcid":false,"given":"Angelo Maria","family":"Minnella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Pagliei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Maceroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Federici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Gambini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Caporossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,6]]},"reference":[{"key":"1787_CR1","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.8493574","volume":"260","author":"F Latif","year":"1993","unstructured":"Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993;260:1317\u201320.","journal-title":"Science"},{"key":"1787_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0039-6257(01)00245-4","volume":"46","author":"AD Singh","year":"2001","unstructured":"Singh AD, Shields CL, Shields JA. Von Hippel-Lindau disease. Surv Ophthalmol. 2001;46:117\u201342.","journal-title":"Surv Ophthalmol"},{"key":"1787_CR3","first-page":"367","volume":"68","author":"RB Welch","year":"1970","unstructured":"Welch RB. Von Hippel-Lindau disease: the recognition and treatment of early angiomatosis retinae and the use of cryosurgery as an adjunct to therapy. Trans Am Ophthalmol Soc. 1970;68:367\u2013424.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"1787_CR4","first-page":"1909","volume":"41","author":"M Niemela","year":"2000","unstructured":"Niemela M, Lemeta S, Sainio M, Rauma S, Pukkala E, Kere J, et al. Hemangioblastomas of the retina: impact of von Hippel-Lindau disease. Invest Ophthalmol Vis Sci. 2000;41:1909\u201315.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1787_CR5","first-page":"47","volume":"5","author":"D Schmidt","year":"2000","unstructured":"Schmidt D, Natt E, Neumann HP. Long-term results of laser treatment for retinal angiomatosis in von Hippel-Lindau disease. Eur J Med Res. 2000;5:47\u201358.","journal-title":"Eur J Med Res"},{"key":"1787_CR6","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/eye.2012.259","volume":"27","author":"VP Papastefanou","year":"2013","unstructured":"Papastefanou VP, Pilli S, Stinghe A, Lotery AJ, Cohen VML. Photodynamic therapy for retinal capillary hemangioma. Eye. 2013;27:438\u201342.","journal-title":"Eye"},{"key":"1787_CR7","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/S0161-6420(02)01177-6","volume":"109","author":"AD Singh","year":"2002","unstructured":"Singh AD, Nouri M, Shields CL, Shields JA, Perez N. Treatment of retinal capillary hemangioma. Ophthalmology. 2002;109:1799\u2013806.","journal-title":"Ophthalmology"},{"key":"1787_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0959-437X(00)00152-0","volume":"11","author":"M Ivan","year":"2001","unstructured":"Ivan M, Kaelin WG. The von Hippel-Lindau tumor suppressor protein. Curr Opin Genet Dev. 2001;11:27\u201334.","journal-title":"Curr Opin Genet Dev"},{"key":"1787_CR9","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrc885","volume":"2","author":"WG Kaelin","year":"2002","unstructured":"Kaelin WG. Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer. 2002;2:673\u201382.","journal-title":"Nat Rev Cancer"},{"key":"1787_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/humu.1380050109","volume":"5","author":"F Chen","year":"1995","unstructured":"Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean M, et al. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat. 1995;5:66\u201375.","journal-title":"Hum Mutat"},{"key":"1787_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1476-5381.1993.tb13553.x","volume":"109","author":"PD Collins","year":"1993","unstructured":"Collins PD, Connolly DT, Williams TJ. Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo. Br J Pharmacol. 1993;109:195\u20139.","journal-title":"Br J Pharmacol"},{"key":"1787_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2174\/1874364101004010066","volume":"4","author":"FN Hrisomalos","year":"2010","unstructured":"Hrisomalos FN, Maturi RK, Pata V. Long-term use of intravitreal bevacizumab (Avastin) for the treatment of von Hippel-Lindau associated retinal hemangioblastomas. Open Ophthalmol J. 2010;4:66\u20139.","journal-title":"Open Ophthalmol J"},{"key":"1787_CR13","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1016\/j.ophtha.2008.04.033","volume":"115","author":"WT Wong","year":"2008","unstructured":"Wong WT, Liang KJ, Hammel K, Coleman HR, Chew EY. Intravitreal ranibizumab therapy for retinal capillary hemangioblastoma related to von Hippel-Lindau disease. Ophthalmology. 2008;115:1957\u201364.","journal-title":"Ophthalmology"},{"key":"1787_CR14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0002-9394(03)00101-6","volume":"136","author":"JF Girmens","year":"2003","unstructured":"Girmens JF, Erginay A, Massin P, Scigalla P, Gaudric A, Richard S. Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas. Am J Ophthalmol. 2003;136:194\u20136.","journal-title":"Am J Ophthalmol"},{"key":"1787_CR15","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","volume":"121","author":"DS Boyer","year":"2014","unstructured":"Boyer DS, Yoon YH, Belfort R, Bandello F, Maturi RK, Augustin AJ, et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology. 2014;121:1904\u201314.","journal-title":"Ophthalmology"},{"key":"1787_CR16","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1016\/j.ophtha.2011.05.014","volume":"118","author":"JA Haller","year":"2011","unstructured":"Haller JA, Bandello F, Belfort R, Blumenkranz MS, Gillies M, Heier J, et al. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology. 2011;118:2453\u201360.","journal-title":"Ophthalmology"},{"key":"1787_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000431198","volume":"55","author":"J Caceres-del-Carpio","year":"2016","unstructured":"Caceres-del-Carpio J, Costa RD, Haider A, Narayanan R, Kuppermann BD. Corticosteroids: triamcinolone, dexamethasone and fluocinolone. Dev Ophthalmol. 2016;55:221\u201331.","journal-title":"Dev Ophthalmol"},{"key":"1787_CR18","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1046\/j.1365-2796.1998.00338.x","volume":"243","author":"D Wittebol-Post","year":"1998","unstructured":"Wittebol-Post D, Hes FJ, Lips CJ. The eye in von Hippel-Lindau disease: long-term follow-up of screening and treatment: recommendations. J Intern Med. 1998;243:555\u201361.","journal-title":"J Intern Med"},{"key":"1787_CR19","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1097\/IAE.0000000000000254","volume":"34","author":"H Kim","year":"2014","unstructured":"Kim H, Yi JH, Kwon HJ, Lee CS, Lee SC. Therapeutic outcomes of retinal hemangioblastomas. Retina. 2014;34:2479\u201386.","journal-title":"Retina"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1787-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-018-1787-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1787-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T09:44:29Z","timestamp":1567763069000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-018-1787-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,6]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1787"],"URL":"https:\/\/doi.org\/10.1186\/s13256-018-1787-8","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2018,9,6]]},"assertion":[{"value":"29 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent for examinations and off-label treatments was obtained from the patient.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"248"}}